Curaleaf Holdings urged Aurora Cannabis shareholders to accept its offer, which it says represents a 45% premium and would combine the companies into the world's largest cannabis firm. The proposed consideration is 0.3463 Curaleaf shares plus US$0.75 in cash for each Aurora share, implying an offer price of US$4.00 based on Aurora's unaffected August 10, 2026 price. Curaleaf said the combined company would operate in 17 countries, generate more than US$1.5 billion in last-twelve-month revenue, produce nearly US$350 million in adjusted EBITDA (a non-GAAP profitability measure), and achieve at least US$40 million in expected annual cost synergies. Curaleaf Chairman and CEO Boris Jordan will host a live Q&A for Aurora shareholders on September 17 at 10:30 a.m. ET. Shareholders must tender their shares by December 1, 2026. Curaleaf said Aurora has refused to engage constructively and argued that Aurora's standalone strategy has been accompanied by falling revenue and adjusted EBITDA, negative operating cash flow and shareholder dilution. The company said its offer materials, registration documents and tender instructions are available through its website, SEDAR+ and the SEC's EDGAR system. The offer has not been approved or disapproved by the SEC or any U.S. state securities commission, and Curaleaf warned that the transaction remains subject to conditions, regulatory matters and other risks.